Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2335 (LINC02335) is a human gene encoding a long intergenic non-coding RNA of unknown function. LINC02335 does not code for a protein but belongs to a family of RNA transcripts (lincRNAs) that can modulate gene regulation, chromatin remodeling, genome architecture. While thousands of lincRNAs exist in mammalian genomes, only a fraction have been functionally studied. There is currently no direct evidence regarding its biological activity, disease relevance, or suitability as a drug target. Its tissue specificity, regulatory mechanisms, and potential involvement in human disorders remain to be elucidated[1][3][7]. Additional notes: - LINC02335 is a valid gene entry per Genecards and standard transcriptome annotations[1]. - The bulk of general lincRNA biology is based on work in other well-characterized lincRNAs, which might not directly apply to LINC02335 without further research[3][7]. - If seeking more structured data on disease association, biomarkers, or druggability, a dedicated experimental or review study on LINC02335 itself would be needed.
Not applicable; no drugs are known to target LINC02335
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2335 (LINC02335).